Weekly Round Up

Healthcare M&A Finds Discipline. Digital Health Finds Momentum

M&A’s discipline in the Americas, quarterly healthtech VC value segmented & digital health finding its foot again.

Why Digital Health Still Can't Scale Enterprise Wide

What prevents digital health companies from achieving enterprise scale, measles cases going through the roof in the US.

The Aging Economy Is Reshaping Healthcare

AI Is Making Healthcare Easier to Build and Harder to Defend

Digital health funding rebounds, Samsung Biologics makes a $1.8B peptide bet, and India looks to become a global healthcare innovation engine.

Healthcare's Capital Is Getting More Selective

Biopharma IPOs reopen, AI reshapes digital health, and margins come under pressure.

The $7B Healthcare Bet + AI’s Next Platform Layer

AI decision support, specialty pharmacy & outbreak detection.

Healthcare's Next $190B Opportunity

GLP-1s are evolving into a multi-disease platform, AI is reshaping pharma operations, and healthcare is regaining investor momentum.

Medicaid's Coverage Reversal, a $10B Bet in Biotech & The Next Digital Health Giant

Medicaid coverage falls, biotech M&A returns, and the next $10B digital health opportunity.

Healthcare AI Is Splitting Into Specialized Markets

How AI, personalized manufacturing, and India's MedTech industry are reshaping healthcare.

Innovation Is Now an M&A Strategy

Healthcare consolidation accelerates, Merck makes an $11B biotech move, innovation takes center stage, and what to expect from Europe's H2 2026 deal market.

The AI Boom Reaching Medical Claims

GLP-1 Medicaid Spending Up 740%: What's Next for Healthcare M&A

Why Healthcare Analytics M&A Is Heating Up

Healthcare Consolidation Meets Europe’s Rural Care Gap.